Clinical Trials Directory

Trials / Completed

CompletedNCT01849705

Melanocortin 4 Receptor Mutations and Obesity-associated Diseases

Mutations in the Melanocortin 4 Receptor and Obesity-associated Diseases

Status
Completed
Phase
Study type
Observational
Enrollment
226 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Mutations in the melanocortin 4 receptor (MC4R) are the most common form of monogenic obesity, and can explain 2-6% of severe obesity. Studies have shown that mutations in MC4R are associated with increased fat mass, height-for-age, appetite and insulin resistance among children. In adults, mutations in MC4R are less penetrant for these phenotypes but it has been observed that individuals with MC4R mutations have a smaller than expected blood pressure for their degree of obesity. The purpose of this study is to explore the association between functional MC4R mutations and obesity, insulin resistance and blood pressure.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention

Timeline

Start date
2012-10-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2013-05-08
Last updated
2013-05-08

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01849705. Inclusion in this directory is not an endorsement.

Melanocortin 4 Receptor Mutations and Obesity-associated Diseases (NCT01849705) · Clinical Trials Directory